Related Experiment Video
Updated: Jan 16, 2026
Rapid Fluorescence-based Characterization of Single Extracellular Vesicles in Human Blood with Nanoparticle-tracking Analysis
Published on: January 7, 2019
Lipoprotein Association Fluorometry (LAF) as a Semi-Quantitative Characterization Tool to Assess Extracellular
Raluca Ghebosu1, Jenifer Pendiuk Goncalves1, Nur Indah Fitri1
1Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
A new assay called lipoprotein association fluorometry (LAF) can quickly measure how extracellular vesicles (EVs) bind to lipoproteins. Cancer cell EVs show increased binding, suggesting potential for new diagnostics and therapeutics.
Area of Science:
- Biochemistry
- Nanotechnology
- Cell Biology
Background:
- Extracellular vesicles (EVs) are nanoparticles involved in physiological processes.
- Lipoproteins can bind to EVs, altering their biological identity.
- Current methods for detecting EV-lipoprotein binding are complex and time-consuming.
Purpose of the Study:
- To develop a rapid and simple assay for quantifying EV-lipoprotein binding.
- To investigate the binding of various EVs to different lipoproteins.
- To explore the potential of EV-lipoprotein interactions in cancer diagnostics.
Main Methods:
- Development of lipoprotein association fluorometry (LAF) using fluorescent lipophilic indocarbocyanine dyes.
- Validation of the LAF assay with synthetic nanoparticles, small molecules, polymers, and proteins.
- Application of the LAF assay to assess binding between EVs from diverse sources and lipoproteins (VLDL, LDL, HDL).
Main Results:
- The LAF assay successfully measured EV-lipoprotein binding across various EV sources.
- EVs from cancerous cells exhibited significantly higher binding to VLDL and LDL compared to normal cell EVs.
- EVs from metastatic cancer cells showed greater VLDL binding than non-metastatic cancer cell EVs.
- Minimal binding was observed between EVs and HDL.
Conclusions:
- The LAF assay provides a simple, rapid, and semi-quantitative method for assessing EV-lipoprotein binding.
- Increased EV-lipoprotein binding in cancer suggests potential diagnostic and therapeutic applications.
- This assay opens new avenues for studying EV biology and developing medical tools.
More Related Videos
08:26Analyzing the Interaction of Fluorescent-Labeled Proteins with Artificial Phospholipid Microvesicles using Quantitative Flow Cytometry
Published on: April 6, 2022
09:12A Quantitative Fluorescence Microscopy-based Single Liposome Assay for Detecting the Compositional Inhomogeneity Between Individual Liposomes
Published on: December 13, 2019